cervical intraepithelial neoplasias(CIN)
Conditions
Interventions
Group 1:bivalent vaccine
Group 2:Tetravalent vaccine
control group:nothing
Sponsors
Family Planning Service Center of YiWu Maternity and Child health care
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) the histology of LEEP confirmed HSIL; (2) both the preoperative and postoperative results of human papillomavirus (HPV) (hr-hpv) were obtained from patients tested by human papillomavirus (HPV) DNA chips; (3) those who did not receive HPV tetravalent or bivalent vaccine before HSIL diagnosis; (4) patients who were followed for at least two years; (5) signing the informed consent.
Exclusion criteria
Exclusion criteria: (1) after LEEP, histopathology confirmed positive cutting edge; (2) fertility requirement within a short period (within 6 months after surgery); (3) age < 45 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HSIL recurrence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cervical cytology;HPV; | — |
Countries
China
Contacts
Public ContactWu Lili
Family Planning Service Center of YiWu Maternity and Child health care
Outcome results
None listed